Mode
Text Size
Log in / Sign up
Phase 4 N=84 Randomized Double-blind Treatment

Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery

Pain

Enrolled (actual)
84
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Pain Score on Movement (Sitting in Bed From a Supine Position) — 5; 5 score on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Ropivacaine (Drug); Ketorolac (Drug); Placebo (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Duke University
Primary completion
Mar 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Score on Movement (Sitting in Bed From a Supine Position)
5; 5
SECONDARY
Pain Scores at Rest
2; 2
SECONDARY
Pain Scores at Rest
2; 2
SECONDARY
Pain Scores at Rest
2; 2
SECONDARY
Opioid Consumption
20; 10
SECONDARY
Opioid Consumption
20; 10
SECONDARY
Opioid Consumption
20; 10
SECONDARY
Time to First Rescue Analgesic
660; 954
SECONDARY
Number of Subjects Experiencing Nausea
4; 1
SECONDARY
Number of Subjects Experiencing Nausea
4; 1
SECONDARY
Number of Subjects Experiencing Nausea
4; 1
SECONDARY
Number of Subjects Experiencing Vomiting
1; 0
SECONDARY
Number of Subjects Experiencing Vomiting
1; 0
SECONDARY
Number of Subjects Experiencing Vomiting
1; 0
SECONDARY
Number of Subjects Experiencing Pruritus
0; 0
SECONDARY
Number of Subjects Experiencing Pruritus
0; 0
SECONDARY
Number of Subjects Experiencing Pruritus
0; 0
SECONDARY
Patient Satisfaction With Postoperative Analgesia on a 0-10 Scale
9.5; 8
SECONDARY
Number of Subjects With Chronic Pain
0; 0
SECONDARY
Number of Subjects With Chronic Pain
0; 0
SECONDARY
Postpartum Depression, as Measured by the Edinburgh Postnatal Depression Scale
3; 1
SECONDARY
Postpartum Depression, as Measured by the Edinburgh Postnatal Depression Scale
3; 1
SECONDARY
Pain Score on Movement
5.5; 5

Summary

The purpose of this study is to determine if the infusion of the local anesthetic ropivacaine (a numbing medicine) and the non-steroidal anti-inflammatory drug ketorolac (a pain killer similar to ibuprofen) through a catheter placed along the cesarean delivery incision, will reduce the pain experienced after cesarean section and need for narcotic pain medicine.

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiology (ASA) class 1,2, and 3
  • English speaking women at a gestational age > 37 weeks
  • scheduled for cesarean delivery under spinal or combined spinal epidural anesthesia

Exclusion Criteria

  • BMI > 50 kg/m2
  • history of intravenous drug or opioid abuse
  • previous history of chronic pain syndrome
  • history of opioid use in the past week
  • allergy or contraindication to any of the study medications
  • non-English speaking
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02829944). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search